No association between omalizumab use and risk of cancer: a nationwide registry-based cohort study

Publikation: Bidrag til tidsskriftLetterfagfællebedømt

Standard

No association between omalizumab use and risk of cancer : a nationwide registry-based cohort study. / Ali, Zarqa; Egeberg, Alexander; Thyssen, Jacob P.; Sorensen, Jennifer Astrup; Vestergaard, Christian; Thomsen, Simon Francis.

I: British Journal of Dermatology, Bind 186, Nr. 4, 2022.

Publikation: Bidrag til tidsskriftLetterfagfællebedømt

Harvard

Ali, Z, Egeberg, A, Thyssen, JP, Sorensen, JA, Vestergaard, C & Thomsen, SF 2022, 'No association between omalizumab use and risk of cancer: a nationwide registry-based cohort study', British Journal of Dermatology, bind 186, nr. 4. https://doi.org/10.1111/bjd.20941

APA

Ali, Z., Egeberg, A., Thyssen, J. P., Sorensen, J. A., Vestergaard, C., & Thomsen, S. F. (2022). No association between omalizumab use and risk of cancer: a nationwide registry-based cohort study. British Journal of Dermatology, 186(4). https://doi.org/10.1111/bjd.20941

Vancouver

Ali Z, Egeberg A, Thyssen JP, Sorensen JA, Vestergaard C, Thomsen SF. No association between omalizumab use and risk of cancer: a nationwide registry-based cohort study. British Journal of Dermatology. 2022;186(4). https://doi.org/10.1111/bjd.20941

Author

Ali, Zarqa ; Egeberg, Alexander ; Thyssen, Jacob P. ; Sorensen, Jennifer Astrup ; Vestergaard, Christian ; Thomsen, Simon Francis. / No association between omalizumab use and risk of cancer : a nationwide registry-based cohort study. I: British Journal of Dermatology. 2022 ; Bind 186, Nr. 4.

Bibtex

@article{4134bd1b07c4400bb15550ad10cf1cd0,
title = "No association between omalizumab use and risk of cancer: a nationwide registry-based cohort study",
author = "Zarqa Ali and Alexander Egeberg and Thyssen, {Jacob P.} and Sorensen, {Jennifer Astrup} and Christian Vestergaard and Thomsen, {Simon Francis}",
year = "2022",
doi = "10.1111/bjd.20941",
language = "English",
volume = "186",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - No association between omalizumab use and risk of cancer

T2 - a nationwide registry-based cohort study

AU - Ali, Zarqa

AU - Egeberg, Alexander

AU - Thyssen, Jacob P.

AU - Sorensen, Jennifer Astrup

AU - Vestergaard, Christian

AU - Thomsen, Simon Francis

PY - 2022

Y1 - 2022

U2 - 10.1111/bjd.20941

DO - 10.1111/bjd.20941

M3 - Letter

C2 - 34878656

VL - 186

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 4

ER -

ID: 291537500